This excerpt taken from the TPTX DEF 14A filed Jun 19, 2009.
These excerpts taken from the TPTX 10-K filed Mar 27, 2009.
FACE="Times New Roman" SIZE="2">Forward-Looking Statements
This Annual Report on Form 10-K contains forward-looking statements
countries. We may also refer to trademarks of other corporations and organizations in this document.
Our common stock is currently
The following table sets forth the range of high and low sales prices of our common stock for the quarterly periods
SIZE="2">Directors of the Registrant
Our directors as of March 15, 2009 are as follows:STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">
Peter Davis, Ph.D., has served as a director of our Company since October 2006 and the
Jean Deleage, Ph.D.
Steven H. Ferris,
Jason Fisherman, M.D. has served as a director of our Company since October 2006 and
Chief Executive Officer from September 2008 to November 2008 and as our Chief Operating Officer from October 2006 to August 2008. Ms. Graham joined TPTX, Inc., our subsidiary, in 2004 as Vice President, Development; she became TPTX
Inc.s Vice President, Corporate Development in 2005 and Chief Operating Officer in 2006. Ms. Graham was Executive Director, Development Operations at Purdue Pharma, a privately-held pharmaceutical company, from 2000 to 2003. From 1998 to
2000, Ms. Graham was Senior Vice President of Business Development of Ingenix Pharmaceutical Services, a health information technology company and a division of UHG, and served as Vice President of Clinical Operations at Worldwide Clinical
Trials, a contract research organization, prior to its acquisition by UHG. Previously, Ms. Graham held positions in operations management, healthcare utilization, and organizational planning at Bayer Corporation and Wyeth Pharmaceuticals
(formerly Ayerst Laboratories). Ms. Graham holds a B.A. in biology from the University of Delaware and an M.B.A. from the University of Connecticut.
FACE="Times New Roman" SIZE="2">Steven B. Ratoff has served as a director of our Company since May 2005. From September 2005 to October 2006, Mr. Ratoff served as the Chairman of our Board. Mr. Ratoff is currently a
Patrick Van Beneden has served as a director of our Company since October 2006 and previously served as a director